NL-OMON28948尚未招募不适用
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.
VU University Medical Center0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with NSCLC, planned to receive erlotinib for therapy will be included in this study. Ten evaluable patients are needed. It is expected that this number of patients will be recruited within 1 year.
- •1. Patients age: Between 18 and 70 years;
排除标准
- •1. Claustrophobia;
- •2. Pregnant or lactating patients;
研究者
相似试验
已完成
不适用
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.non-small cell lung carcinoma10038666lung cancerNL-OMON36826Vrije Universiteit Medisch Centrum10
已完成
不适用
Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancerAdvanced non-small cell lung cancerJPRN-UMIN000012862Shizuoka cancer center70
已完成
不适用
[11C]Erlotinib tumor heterogeneity: an in vivo study using static whole body positron emission tomography in non-small cell lung cancer patients.lung cancerNL-OMON44987Vrije Universiteit Medisch Centrum30
招募中
不适用
Imaging of [11C]erlotinib pharmacokinetics in non small cell lung cancer patients; an in vivo study with positron emission tomography10038666lung cancerNL-OMON32923Vrije Universiteit Medisch Centrum10
进行中（未招募）
不适用
Pharmacodynamic study of Erlotinib (Tarceva) in patients with mestastatic or locally advanced Epidermoid carcinoma of the head and neckMestastatic or locally advanced Epidermoid carcinoma of the head and neckEUCTR2005-003814-14-ESnidad Integral de Investigación en Oncología, S.L.49